- Tytuł:
- The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells.
- Autorzy:
- Źródło:
-
Scientific reports [Sci Rep] 2021 May 24; Vol. 11 (1), pp. 10791. Date of Electronic Publication: 2021 May 24. - Typ publikacji:
- Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Drug Resistance, Neoplasm*/drug effects
ATP Binding Cassette Transporter ,Subfamily G ,Member 2 /*metabolism
Carcinoma, Hepatocellular/*metabolism
Doxorubicin/*pharmacology
Liver Neoplasms/*metabolism
Neoplasm Proteins/*metabolism
Neoplastic Stem Cells/*metabolismATP Binding Cassette Transporter ,Subfamily B/antagonists & inhibitors ;ATP Binding Cassette Transporter ,Subfamily B/metabolism ;ATP Binding Cassette Transporter ,Subfamily G ,Member 2 /antagonists & inhibitors ; Carcinoma, Hepatocellular/drug therapy ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Cyclosporins/pharmacology ; Diketopiperazines/pharmacology ; Drug Synergism ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Silencing ; Heterocyclic Compounds, 4 or More Rings/pharmacology ; Humans ; Liver Neoplasms/drug therapy ; Neoplasm Proteins/antagonists & inhibitors ; Neoplastic Stem Cells/drug effects ; Up-Regulation/drug effects
Czasopismo naukowe